Emergency Coronary Artery Bypass Graft in Acute Myocardial Infarction

Acute Myocardial Infarction Clinical Trial

Official title:

Emergency Coronary Artery Bypass Graft in Acute Myocardial Infarction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04572061
• Other study ID #: SBCC-2017-04
• Status: Completed
• Start date: February 7, 2017
• Est. completion date: July 31, 2018

Study information

• Verified date: September 2020
• Source: Saud Al Babtain Cardiac Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A retrospective study investigating the early outcome of emergency CABG post MI in patients who were operated at Saud Al Babtain Cardiac Center.

Description:

A retrospective study of surgical patients who underwent Coronary Artery Bypass Graft for Acute Myocardial Infarction between December 2013 and February 2018 determining outcomes on morbidity and mortality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 109
• Est. completion date: July 31, 2018
• Est. primary completion date: October 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 17 Years and older

Eligibility

Inclusion Criteria:

• Patients with post cardiogenic shock who underwent CABG

• =/> 17 years old

Exclusion Criteria:

• Patients other than post cardiogenic shock who underwent CABG or any cardiac surgeries

• <17 years old

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Emergencies
• Infarction
• Myocardial Infarction

Locations

Country	Name	City	State
Saudi Arabia	Saud Al Babtain Cardiac Center	Dammam

Sponsors (1)

Lead Sponsor	Collaborator
Saud Al Babtain Cardiac Center

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	STEMI and Emergency CABG	Evaluate patients the early outcome of emergency CABG post MI.	1 year